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Results: For prostate the average value of the D99% were 
99.19% ± 0.25%, 79.62% ± 13.23%, 91.42% ± 7.19% of 
prescribed dose, for 0º, -27º, +27º rotation angles 
respectively. For IMRT and SIB-IMRT techniques decrease of 
D99% was reduced for maximum angles by 12% and 26.5% 
respectively and results were rotation direction independent. 
The rotation had no impact on D1%. A negligible influence of 
rotation for 3D-CRT and IMRT on the Dmean was observed. For 
3D-CRT and IMRT techniques decreased of Dmean was greater 
than 2% only for maximum analyzed angles in 1 and 3 cases 
respectively. For SIB-IMRT, the 2% decrease of Dmean was 
observed for 5 patients for rotations larger than 21º, 
regardless of the direction of rotation. For group of 8 
patients with low grade tumors the average value of the TCP 
for non-rotated prostate were calculated and equal to 83.4% 
± 0.2% and 83.3% ± 0.3% for 3D-CRT and IMRT respectively. 
For rotations smaller than 18º the TCP was close to 80% for 
all patients. For SIB-IMRT plans the TCP decreased from 88.3 
% to 80.0% for 18º rotations.  
Conclusions: Our results showed that the change of dose 
distribution in the target volume depend on the angle of 
rotation and the treatment delivery technique. Only rotations 
larger than about 21o influence significantly on the DVH and 
the TCP. The 3D-CRT showed the smallest sensitivity to 
prostate rotations. SIB-IMRT technique was the most sensitive 
to rotations, however the increased prescribed dose to 
prostate compensated reduction in the TCP. It remained 
comparable to the TCP obtained for 3D-CRT and IMRT 
techniques.  
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Purpose/Objective: To compare lipiodol and diaphragm as 
tumor surrogate in hypofractionated radiotherapy of 
hepatocellular carcinomas (HCC) using 4D cone beam 
computed tomography (CBCT). 
Materials and Methods: Treatment verification 4DCBCT scan 
were acquired using Elekta XVI v.4.5 (Elekta, Crawley, UK) 
for 15 HCC patients who had prior single transarterial 
chemoembolization (TACE) with lipiodol. Automatic 4DCBCT 
image registration with the planning mid-ventilation images 
was performed initially by bone registration of the vertebrae 
followed by a 4D registration based on either lipiodol or 
diaphragm on the reconstructed time-weighted average 
images. Uncertainties of treatment setup and interfractional 
tumor baseline drift estimated by lipiodol and diaphragm 
were analyzed. 
Results: All lipiodolized HCCs were clearly visualized on the 
time-weighted average 4D CBCT images. Lipiodol visibility 
decreased with increasing tumor size due to limited amount 
of lipiodol per TACE. Group means and random errors of the 
treatment setup and interfractional baseline shift based on 
lipiodol and diaphragm are similar, agree to within 0.5 mm in 
left-right (LR) and anterior-posterior (AP), and 0.1 mm in 
cranio-caudal (CC) directions, and systematic errors differ by 
1.5 mm, 0.7 mm and 0.2 mm in the LR, AP and CC directions, 
respectively. Using lipiodol instead of diaphragm as tumor 
surrogate in our margin calculation led to 0.6 mm decrease in 
the CC direction, 1.3 mm and 3.1 mm increase in AP and LR 
directions in the patient cohort, respectively. 
Conclusions: Lipiodol offers the potential of target 
localization with motion blurring minimized on the 4D CBCT 
images. Using diaphragm as tumor surrogate can lead to 
misalignment of the tumor. The amount of TACE lipiodol may 
need to be adjusted according to the tumor size to improve 
its visibility on 4D CBCT. 
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Purpose/Objective: Cervical cancer is the fourth most 
common cancer in women with an estimate of 266’000 death 
per year worldwide. It has been reported that by combining 
HDR brachytherapy (HDR) with external beam radiotherapy 
(EBRT) the local tumor control can be further improved. The 
dose distributions for these two treatment modalities are 
based on CTs which differ in the patient positioning. The 
dose planned with EBRT and HDR has to be added together in 
order to assess the dose to the target and to the organ at 
risk. Furthermore, the medial field border for EBRT will be 
based on the dose distribution from the HDR plan. In order to 
propagate the dose from one CT to the other, image 
registration is required. In this work we evaluated the benefit 
of using a non-rigid algorithm compared to a rigid registration 
for dose propagation. 
Materials and Methods: Ten patients treated with HDR 
(5x5Gy, Manchester method) combined with Boost-EBRT to 
the parametrium (3x2Gy) were included in this study. The 
EBRT treatment consisted of 2 opposing fields, in which the 
medial border was based on the 50-80% isodose line from the 
first HDR treatment. The total dose was calculated by 
registering the CT in a rigid or a non-rigid way using Velocity 
(Varian Medical System, Palo Alto, CA). The total dose 
obtained with the rigid and non-rigid registration was then 
compared together based on dose distribution as well as 
dose-volume histogram parameters.  
Results: The position of the 50% HDR isodose line propagated 
on the EBRT CT between the rigid and non-rigid registration 
was different by up to 1cm in all directions, thus 
substantially affecting the choice of field size for the 
subsequent EBRT. The change of dose distribution between 
both registration modalities did not affect the dose to the 
femoral heads. Larger dose difference to the rectum and 
bladder was observed. Dose to 0.1cm3, 1cm3, 2cm3 and 
5cm3 of the rectum volume could increase by up to 37%, 22%, 
18% and 10%, respectively. For the bladder, dose to 0.1cm3, 
1cm3, 2cm3 and 5cm3 could change by more than 41%, 21%, 
22% and 28%, respectively.  
Conclusions: The registration modality used for dose 
propagation has to be carefully evaluated when matching CTs 
were taken with the patient lying in different positions, as is 
the case in HDR and EBRT. Wrong registration could results in 
cold spots in the tumor region or hot spots in the organs at 
risk. 
   
